Kits and Marker Reagents use “patented magnetic nanoparticles, called ferrofluids…conjugated to antibodies directed against rare cells, including circulating tumor cells and circulating endothelial cells. After the rare cells are enriched from the patient sample, they are fluorescently labeled.”
